Stock SRZN SURROZEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Surrozen, Inc.

Equities

SRZN

US86889P2083

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
10.15 USD -0.03% Intraday chart for Surrozen, Inc. -0.78% +7.98%
May. 09 Surrozen, Inc. Presents Data Demonstrating the Promise of Antibody-Based Wntimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology Annual Meeting CI
May. 08 Surrozen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. SRZN Stock
  4. Revisions Surrozen, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW